Hearing brainwaves
17 July, 2013Listening to the electrical activity of the brain may provide a more effective way of diagnosing and managing epilepsy.
Science literacy declining
17 July, 2013Scientific literacy is falling among young adults and to a lesser degree among the broader Australian adult population.
Probing microbial dark matter
15 July, 2013Researchers have developed a technique for mapping and characterising microbial ‘dark matter’ in the environment.
ImmunAid gets US patent for immune cycle tech
11 July, 2013 by Dylan Bushell-EmblingImmunAid has secured the first US patent covering its strategy involving optimising the time to deliver treatments such as chemotherapy based on patients’ immune system cycles.
Laureate Fellowships and bionic eye funding
11 July, 2013The Australian Research Council (ARC) has awarded $47 million in research funding in the 2013 Australian Laureate Fellowships and an additional $10 million for research on the bionic eye.
New role discovered for macrophages
10 July, 2013Macrophages play a critical role in fertility by creating a healthy hormone environment in the uterus.
Mapping the developing mind
09 July, 2013 by Susan WilliamsonComprehensive mapping of the human brain epigenome has revealed patterns of methylation that occur during the formation of brain circuitry.
University funding cuts to be re-examined
04 July, 2013With the Australian National University announcing cuts to jobs, the new higher education minister plans to re-evaluate university funding
Allied Healthcare increases stake in vaccine
03 July, 2013A next-generation therapeutic vaccine for genital herpes has received an investment boost from Allied Healthcare Group.
Biomolecular in the bush - a life sentence
03 July, 2013 by Susan WilliamsonThe RACI Division of Biomolecular Chemistry will hold its 2013 conference in the Blue Mountains in July. With themes of medicinal chemistry, chemical biology and drug discovery, here is a taste of what the meeting has in store.
AmpliPhi teams with US army on bacteriophage R&D
02 July, 2013 by Dylan Bushell-EmblingAmpliPhi and US army researchers will collaborate on treatments for antibiotic-resistant bacterial infections including Staphylococcus aureus.
AmpliPhi raises $7m in placement
01 July, 2013 by Dylan Bushell-EmblingAmpliPhi, the US bacteriophage company which merged with Australia’s Special Phage Services last year, has raised $7m in a private placement.
Mesoblast gets ethics nod for diabetes trial
27 June, 2013 by Dylan Bushell-EmblingMesoblast (ASX:MSB) has been granted ethics approval for a phase II trial of its mesenchymal precursor cells in patients with diabetic nephropathy.
Biomolecular in the bush - towards antibacterials without resistance
26 June, 2013 by Susan WilliamsonThe RACI Division of Biomolecular Chemistry will hold its 2013 conference in the Blue Mountains in July. With themes of medicinal chemistry, chemical biology and drug discovery, here is a taste of what the meeting has in store.
Putting the brakes on bacterial biofilms
25 June, 2013New insights into how bacteria colonise surfaces may help deal with biofilms that develop on implanted medical devices.
